Revolutionizing Diabetes and Obesity Management: A Comprehensive Review of Tirzepatide's Dual Agonist Approach
Tirzepatide, an innovative glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist, has emerged as a promising therapeutic avenue for type 2 diabetes and obesity management. This review encompasses a comprehensive evaluation of Tirzepatide's mechanism of action, clinical efficacy, sa...
Saved in:
Main Authors: | Sonam Samal (Author), Sourav Maiti (Author), Jonnalagadda Vihari (Author) |
---|---|
Format: | Book |
Published: |
Dr. Annil Mahajan,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tirzepatide - a novel dual GLP-1 and GIP receptor agonist used in pharmacotherapy of obesity: A literature review
by: Bartłomiej Stachyra, et al.
Published: (2023) -
Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
by: Wang L
Published: (2022) -
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide
by: Karen Schneck, et al.
Published: (2024) -
Tirzepatide - A Revolution in Obesity Treatment?
by: Aleksandra Jaroń, et al.
Published: (2024) -
Tirzepatide for type 2 diabetes
by: Sarah L Anderson, et al.
Published: (2023)